HONcode Certified

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

Bloggers

Carl Heneghan

Carl Heneghan

Director of the CEBM, GP and clinical lecturer at the University of Oxford.

Ami Banerjee

Ami Banerjee

Cardiology trainee and clinical research fellow at the University of Oxford

Tags

aid
BMJ
BNP
CHD
FDA
flu
GDP
INR
NGO
NHS
RCT

Carl Heneghan in action

CEBM Workshops Video Sample - Carl Heneghan - Diagnostic Tests

See Carl Heneghan in action in the CEBM's workshop videos.
Click here

Twitter TrustTheEvidence.net

tte

    Search the TRIP Database

    TRIP Database


    cholera

    Diarrhoea-a neglected cause of child mortality

    Ami Banerjee
    Posted 20th October 2009 @ 12:02pm

    This week, the Lancet released two articles in its “Online First” section, both concerned with the second leading global cause of infant death: diarrhoea. A staggering one in every five child deaths—around 1•5 million a year —is due to diarrhoea, which kills more children than AIDS, malaria, and measles combined. I have previously blogged about the Zimbabwean cholera crisis and the tragedy of the long-established, but poorly translated treatments for diarrhoea. The first article draws attention to a new UNICEF report: “Diarrhoea: why children are still dying and what can be done”, and suggests a seven-point plan for diarrhoea control:

    Prevention

    1. Rotavirus and measles vaccinations
    2. Promotion of early and exclusive breastfeeding and vitamin A supplementation
    3. Promotion of handwashing with soap
    4. Improve water quantity and quality, including treatment and safe storage of household water
    5. Promotion of community-wide sanitation

    Treatment

    1. Fluid replacement to prevent dehydration
    2. Zinc supplements
      The authors find that only 39% of children with diarrhoea in developing countries are receiving these simple, cheap interventions.

    The other, more hopeful Lancet article concerns a trial of a new cholera vaccine in more than 65 000 individuals, including children older than 1 year, living in an urban slum in India. Clusters of households were either allocated two doses of the vaccine or the placebo. At 2 years, the vaccine did not have any more side effects than the placebo and was 67% effective in protecting against cholera in the entire population. The vaccine was 49% protective against cholera in children aged 1—5 years, although its effectiveness dropped if the vaccine was not given in two doses. This vaccine is both effective and affordable, giving it great potential for mass immunisation programmes in cholera-endemic areas.

    Lost in translation-lessons from cholera

    Ami Banerjee
    Posted 9th February 2009 @ 10:13pm

    The recent cholera outbreak is the worst in Zimbabwe's history, infecting 66,000 people with over 3,300 deaths [1, 2]. Last week, a Red Cross worker wrote a diary from Zimbabwe for the BBC [1]. Despite technological advances it revealed the desperate circumstances under which people are providing and receiving health care in parts of the world, even when the evidence for cause and cure is beyond doubt.

    Syndicate content